You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Can Positive Framing Reduce Nocebo Side Effects? Current Evidence and Recommendation for Future Research
|
|---|---|
| Published in |
Frontiers in Pharmacology, March 2019
|
| DOI | 10.3389/fphar.2019.00167 |
| Pubmed ID | |
| Authors |
Kirsten Barnes, Kate Faasse, Andrew L. Geers, Suzanne G. Helfer, Louise Sharpe, Luana Colloca, Ben Colagiuri |
X Demographics
The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 5 | 17% |
| United States | 5 | 17% |
| Austria | 2 | 7% |
| United Kingdom | 2 | 7% |
| Switzerland | 1 | 3% |
| Japan | 1 | 3% |
| Réunion | 1 | 3% |
| Unknown | 12 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 59% |
| Scientists | 8 | 28% |
| Practitioners (doctors, other healthcare professionals) | 3 | 10% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 92 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 15% |
| Student > Bachelor | 12 | 13% |
| Researcher | 9 | 10% |
| Student > Ph. D. Student | 8 | 9% |
| Other | 7 | 8% |
| Other | 20 | 22% |
| Unknown | 22 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 24 | 26% |
| Medicine and Dentistry | 12 | 13% |
| Nursing and Health Professions | 6 | 7% |
| Social Sciences | 4 | 4% |
| Business, Management and Accounting | 3 | 3% |
| Other | 13 | 14% |
| Unknown | 30 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 92. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 August 2022.
All research outputs
#429,072
of 24,291,750 outputs
Outputs from Frontiers in Pharmacology
#154
of 18,210 outputs
Outputs of similar age
#10,214
of 356,681 outputs
Outputs of similar age from Frontiers in Pharmacology
#4
of 351 outputs
Altmetric has tracked 24,291,750 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,210 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,681 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 351 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.